Article
24 Mar 2026
Breaking Barriers: Mastering FDA Regulations, National Security, And Tariffs To Expand Your MedTech Company To The U.S.
AUTHORS CONTENT
Article
26 Feb 2026
Senate HELP Committee Releases FDA Modernization Report: "Patients And Families First: Building The FDA Of The Future"
Article
23 Feb 2026
FDA Announces New Enforcement Policy On "No Artificial Colors" Food Labeling
Article
29 Jan 2025
Navigating The FDA's Final Interim Policy On Compounding With Bulk Drug Substances: A Guide For 503A Pharmacies And 503B Outsourcing Facilities
Article
20 Jan 2025
4 Potential FDA Drug Approvals To Watch In 2025
Article
10 Jun 2024
Oregon Proposes New Annual Fee For Drug Manufacturers
Article
07 Nov 2023
White House Issues Groundbreaking Executive Order On Artificial Intelligence
Article
17 Oct 2023
Artificial Intelligence And Machine Learning: The Next Frontier Of Drug Development?
Article
17 Aug 2023
Key Steps To Prepare for FDA's New Medical Device Cybersecurity Rules
Article
22 May 2023
DOJ Scrutinizes Telemedicine & Remote Patient Monitoring Fraud: What You Need To Know
Article
04 May 2023
3 Ways Private Equity Firms Can Protect Themselves From False Claims Act Lawsuits & DOJ Scrutiny
Article
01 May 2023
FTC Issues Notice Of Penalty Offenses: Companies Warned To Substantiate Product & Advertising Claims
Article
21 Mar 2023
The New Face Of Cosmetics: The Modernization Of Cosmetics Regulation Act Of 2022
Article
06 Feb 2023
FDA Concludes That A New Regulatory Pathway For CBD Is Needed
Article
01 Mar 2022
Preparing Pharmaceutical Manufacturers: Prescription Drug Price Transparency Laws Update
Article
02 Jun 2021
HHS And FDA Withdraw Previous Notice, Reinstitute Unapproved Drug Initiative
Article
05 Apr 2021
FDA Reissues OTC Monograph User Fees
Article
12 Jan 2021
HHS Washes Its Hands Of FDA's OTC Sanitizer User Fees
Article
06 Jan 2021
More FDA Enforcement Against CBD Companies
Article
21 Dec 2020
Operation CBDeceit: FTC Cracks Down On False And Misleading CBD Advertising